These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24060850)

  • 21. Hepatitis C virus entry: possible targets for therapy.
    Timpe JM; McKeating JA
    Gut; 2008 Dec; 57(12):1728-37. PubMed ID: 19022929
    [No Abstract]   [Full Text] [Related]  

  • 22. The ins and outs of hepatitis C virus entry and assembly.
    Lindenbach BD; Rice CM
    Nat Rev Microbiol; 2013 Oct; 11(10):688-700. PubMed ID: 24018384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locking out hepatitis C.
    Gerold G; Rice CM
    Nat Med; 2011 May; 17(5):542-4. PubMed ID: 21546968
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
    Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
    Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Host Factor Erlin-1 is Required for Efficient Hepatitis C Virus Infection.
    Whitten-Bauer C; Chung J; Gómez-Moreno A; Gomollón-Zueco P; Huber MD; Gerace L; Garaigorta U
    Cells; 2019 Dec; 8(12):. PubMed ID: 31810281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
    Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
    J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
    Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarities and Differences Between HCV Pseudoparticle (HCVpp) and Cell Culture HCV (HCVcc) in the Study of HCV.
    Riva L; Dubuisson J
    Methods Mol Biol; 2019; 1911():33-45. PubMed ID: 30593616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
    Régeard M; Trotard M; Lepère C; Gripon P; Le Seyec J
    J Viral Hepat; 2008 Dec; 15(12):865-70. PubMed ID: 19087225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
    Beard MR; Ffrench R; Gowans EJ; Helbig KJ; Eyre NM; Douglas MM; Grebely J; Ahlenstiel G; Locarnini S; George J; Shackel NA; White PA; Thompson AJ; Drummer HE
    Gastroenterology; 2014 Jul; 147(1):e1-4. PubMed ID: 24861641
    [No Abstract]   [Full Text] [Related]  

  • 32. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
    Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S
    Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Completion of the entire hepatitis C virus life cycle in genetically humanized mice.
    Dorner M; Horwitz JA; Donovan BM; Labitt RN; Budell WC; Friling T; Vogt A; Catanese MT; Satoh T; Kawai T; Akira S; Law M; Rice CM; Ploss A
    Nature; 2013 Sep; 501(7466):237-41. PubMed ID: 23903655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus replication in patients with occult hepatitis C virus infection.
    Carreño V; Bartolomé J; Castillo I; Quiroga JA
    Hepatology; 2009 Jun; 49(6):2128-9; author reply 2129. PubMed ID: 19475689
    [No Abstract]   [Full Text] [Related]  

  • 36. Establishment of mice with inheritable susceptibility to productive hepatitis C virus infection.
    Uprichard SL
    Hepatology; 2014 May; 59(5):2043-6. PubMed ID: 24277664
    [No Abstract]   [Full Text] [Related]  

  • 37. Reply: To PMID 21294144.
    Mensa L; Perez-del-Pulgar S; Forns X
    Hepatology; 2013 Feb; 57(2):855. PubMed ID: 22729894
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
    Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
    Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection.
    Wang J; Qiao L; Hou Z; Luo G
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.
    Gerold G; Bruening J; Weigel B; Pietschmann T
    Mol Cell Proteomics; 2017 Apr; 16(4 suppl 1):S75-S91. PubMed ID: 28077444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.